Stockscreener 앱 받기
13.98
0.94%
0.13
전일 마감가:
$13.85
열려 있는:
$13.91
하루 거래량:
21,221
Relative Volume:
0.24
시가총액:
$381.69M
수익:
$56.44M
순이익/손실:
$-32.60M
주가수익비율:
-11.35
EPS:
-1.2318
순현금흐름:
$-35.15M
1주 성능:
-0.50%
1개월 성능:
-8.21%
6개월 성능:
+27.67%
1년 성능:
+2.42%
1일 변동 폭
$13.85
$14.32
1주일 범위
$13.76
$15.00
52주 변동 폭
$8.50
$17.23
Carlsmed Inc Stock (CARL) Company Profile
명칭
Carlsmed Inc
전화
858-295-9290
주소
1800 ASTON AVENUE, CARLSBAD
Compare CARL vs VEEV, TEM, BTSG, HNGE, HQY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
13.98 | 381.69M | 56.44M | -32.60M | -35.15M | -1.2318 |
VEEV
Veeva Systems Inc
|
313.06 | 50.69B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
71.15 | 12.92B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
62.35 | 12.34B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
104.92 | 8.47B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
92.54 | 7.65B | 1.34B | 230.70M | 440.96M | 2.6695 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-07-01 | 개시 | Needham | Buy |
| 2025-08-18 | 개시 | BTIG Research | Buy |
| 2025-08-18 | 개시 | BofA Securities | Buy |
| 2025-08-18 | 개시 | Goldman | Buy |
| 2025-08-18 | 개시 | Piper Sandler | Overweight |
| 2025-08-18 | 개시 | Truist | Buy |
모두보기
Carlsmed Inc 주식(CARL)의 최신 뉴스
Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System - GlobeNewswire Inc.
Carlsmed Officer Jeffrey Bertolini Files Form 144 to Sell 747 Shares Acquired via Stock Option - Kalkine Media
Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Form 4 Carlsmed Inc For: 2 October By Investing.com - Investing.com South Africa
Form 4 Carlsmed Inc For: 2 October By Investing.com - Investing.com Canada
At $13.99 a share, Carlsmed (CARL) COO sells 243 shares under a prearranged trading plan. - Stock Titan
Form 4 Carlsmed Inc For: 30 September By Investing.com - Investing.com South Africa
Form 4 Carlsmed Inc For: 30 September By Investing.com - Investing.com UK
Stock awards for Carlsmed (CARL)'s CFO include 89,286 units and options exercisable at $14.18. - Stock Titan
Presidio Management Group XII buys $3m in Carlsmed stock By Investing.com - Investing.com India
Presidio Management Group XII buys $3m in Carlsmed stock By Investing.com - Investing.com Canada
Presidio Management Group XII buys $3m in Carlsmed stock - Investing.com
Ten percent owner boosts stake in Carlsmed (CARL) - Stock Titan
Carlsmed COO Jeffrey Bertolini Awarded 50,000 Stock Options with $15.23 Exercise Price - Kalkine Media
Carlsmed (CARL) awards COO 50,000 stock options - Stock Titan
Carlsmed (CARL) COO discloses 22,489-share stake - Stock Titan
Carlsmed, Inc.: Shareholders Board Members Managers and Company Profile | US14280C1053 - marketscreener.com
Carlsmed appoints Jeff Bertolini as new COO - TipRanks
Carlsmed, Inc. Announces Chief Operating Officer Appointment - The Manila Times
Carlsmed names Jeffrey Bertolini as Chief Operating Officer - TradingView
Carlsmed, Inc. Announces Chief Operating Officer Appointment - marketscreener.com
Carlsmed, Inc. Announces Chief Operating Officer Appointment - Yahoo Finance
symbol__ Stock Quote Price and Forecast - cnn.com
BlackRock Inc. Purchases New Holdings in Carlsmed, Inc. $CARL - MarketBeat
Jupiter Topco LLC Acquires New Holdings in Carlsmed, Inc. $CARL - MarketBeat
Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet - qz.com
Parkman Healthcare Partners LLC Invests $6.20 Million in Carlsmed, Inc. $CARL - MarketBeat
Carlsmed (CARL) Earnings Snapshot: EPS Lands Above Forecast on the Day; The Stock Ends Down 1.56% in the Current UpdateDividend Growth Analysis - dars.gov.et
Carlsmed, Inc. (NASDAQ:CARL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to "Hold" - MarketBeat
Carlsmed (CARL) plans up to $250M in stock, debt and warrant sales - Stock Titan
Carlsmed (CARL) Holds Steady Near $13.72 as Tight Range Signals Potential MoveDefined Outcome ETF - vinanet.vn
Carlsmed (CARL) Holds Steady Near $13.72 as Tight Range Signals Potential MoveBearish Sentiment - dars.gov.et
Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform - TradingView
Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform - TradingView
Transcript : Carlsmed, Inc. Presents at Bank of America SMID Cap Virtual Conference, Aug-12-2026 11 - marketscreener.com
CARL: Personalized AI spine surgery platform accelerates growth with new reimbursement and strong clinical data - TradingView
CARL Q2 2026 Earnings: Narrower-Than-Expected Loss but Shares Slip 2.55%Tax Rate Impact - vinanet.vn
Carlsmed, Inc. Common Stock (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - kalkine.ca
Carlsmed, Inc. Common Stock (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - Kalkine
Truist raises Carlsmed stock price target on strong growth outlook By Investing.com - Investing.com South Africa
Carlsmed Buy Rating Reaffirmed as 2026 Outlook Raised and Adoption Grows; $17 Price Target Maintained - TipRanks
Analysts Are Bullish on These NA Stocks: BillionToOne, Inc. Class A (BLLN), Carlsmed, Inc. (CARL) - theglobeandmail.com
Carlsmed Q2 2026 revenue up 57% to USD 18.9M - Medical Buyer
Truist raises Carlsmed stock price target on strong growth outlook - Investing.com Nigeria
CARLSMED INC Q2 NET INCOME USD -10.5 MILLION - Moomoo
Truist raises Carlsmed stock price target on strong growth outlook - Investing.com
Truist Adjusts Price Target on Carlsmed to $20 From $18, Maintains Buy Rating - marketscreener.com
Carlsmed, Inc. Stock 12‑Month Price Target Raised to $19.2, Implies 42% Upside - TradingView
Carlsmed Inc. (CARL) Advances 4.79% to $14.21: Personalized Spine Tech Gains TractionBuy Signal Reports - dars.gov.et
Carlsmed Inc (CARL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Carlsmed Inc 주식 (CARL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bertolini Jeffrey | Chief Operating Officer |
Oct 05 '26 |
Sale |
14.39 |
747 |
10,749 |
22,489 |
| Bertolini Jeffrey | Chief Operating Officer |
Oct 05 '26 |
Option Exercise |
5.92 |
747 |
4,419 |
23,236 |
| Bertolini Jeffrey | Officer |
Oct 05 '26 |
Proposed Sale |
14.39 |
747 |
10,749 |
0 |
| Bertolini Jeffrey | Officer |
Sep 30 '26 |
Proposed Sale |
13.99 |
243 |
3,400 |
0 |
| Bertolini Jeffrey | Chief Operating Officer |
Sep 30 '26 |
Sale |
13.99 |
243 |
3,400 |
22,489 |
| Bertolini Jeffrey | Chief Operating Officer |
Sep 30 '26 |
Option Exercise |
2.23 |
243 |
542 |
22,732 |
| Cordonnier Michael | CEO, President |
Mar 03 '26 |
Option Exercise |
1.02 |
193,831 |
198,555 |
1,550,477 |
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Sale |
13.29 |
197,855 |
2,629,889 |
1,356,646 |
| Cordonnier Michael | Officer |
Mar 02 '26 |
Proposed Sale |
13.29 |
197,855 |
2,629,881 |
0 |
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Option Exercise |
0.34 |
197,855 |
66,281 |
1,554,501 |
0.56%
3.33%
자본화:
|
볼륨(24시간):